Royal Orchid Hotels Limited has received regulatory penalties totaling ₹23,600.00 from both BSE and NSE for delayed filing of related party transaction disclosures. The company disclosed this information on December 17, 2025, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Penalty Details

Both stock exchanges imposed identical fines on the company for non-compliance with Regulation 23(9) of LODR regulations. The violation pertained to delay in submission of related party transactions in the specified format and within the prescribed period.

Reason for Delay

The company provided detailed clarification regarding the circumstances that led to the filing delay. According to the disclosure, the relevant board meeting had concluded in the evening, following which the compliance team initiated the uploading process. While all PDF disclosures were successfully uploaded within the regulatory time period, technical issues arose specifically with the XBRL filing system.

The compliance team made extensive efforts to complete the XBRL submission, working until past midnight. However, since midnight had elapsed, this technically constituted a one-day delay in the filing, resulting in the regulatory penalty.

Filing Details

The delayed submission pertained to the RPT (Related Party Transaction) statement for the half-year ended September 30, 2025, which was due during the quarter ended December 31, 2025. The company received notification of the penalties via email dated December 16, 2025, from both exchanges.

Company Response

Royal Orchid Hotels Limited has confirmed payment of the imposed penalties. The company stated that the financial impact is limited to the penalty amount of ₹11,800.00, with no other material impact on its financial, operational, or other activities. The disclosure was signed by Ranabir Sanyal, Company Secretary and Compliance Officer, emphasizing the company's commitment to regulatory compliance despite the technical challenges encountered during the filing process.

Royal Orchid Hotels has announced the signing of a deal for a new 43-room hotel in Baddi, Himachal Pradesh, marking a strategic expansion into one of India's key industrial regions. The new property, to be named 'Regenta Place Golden Castle,' will be located in what is recognized as Asia's largest pharmaceutical hub.

Strategic Location in Pharmaceutical Hub

The hotel will be situated in Baddi, a prominent industrial town in Himachal Pradesh that has emerged as a major pharmaceutical manufacturing center. The location's significance as Asia's largest pharma hub makes it an attractive destination for business travelers and industry professionals.

Expansion Under Regenta Brand

The new property will operate under Royal Orchid Hotels' Regenta brand, which caters to the mid-market hospitality segment. This addition to the company's portfolio represents continued growth in key business destinations across India.

Market Positioning

By establishing a presence in Baddi, the company is positioning itself to capture demand from the pharmaceutical industry's business travel requirements. The region's industrial significance and concentration of pharmaceutical companies create opportunities for corporate hospitality services.

The 43-room hotel is expected to serve both business travelers visiting the pharmaceutical hub and leisure guests exploring the Himachal Pradesh region. This strategic location choice aligns with the company's expansion strategy in commercially viable markets.